American Society of Hematology, Blood, 1(132), p. 89-100
DOI: 10.1182/blood-2017-11-814244
Full text: Unavailable
Key Points Whole-exome sequencing may identify specific therapeutic opportunities for patients with HLH. HLH should be conceptualized as a critical illness phenotype driven by toxic activation of immune cells from different underlying mechanisms.